文献速递急腹症与外科感染围术期管理与 ERAS

全国儿童队列研究:过敏与复杂性阑尾炎的保护性关联

Nationwide paediatric cohort study of a protective association between allergy and complicated appendicitis.
PubMed 文献 · Br J Surg · 2021-01-01

横断面分析显示过敏儿童复杂性阑尾炎调整OR为0.80(95%CI 0.67-0.96,P=0.021);纵向分析显示过敏儿童复杂性阑尾炎风险降低约三分之一(HR 0.68,95%CI 0.58-0.81,P<0.001),而单纯性阑尾炎风险无变化。季节性抗原暴露为保护因素,持续抗组胺药治疗为危险因素。

要点

  • 过敏儿童发生复杂性阑尾炎的调整OR为0.80,风险降低。
  • 纵向分析中过敏儿童复杂性阑尾炎HR为0.68,单纯性阑尾炎HR为1.00。
  • 季节性抗原暴露降低复杂性阑尾炎风险,抗组胺药治疗增加风险。

核心结论

  • 过敏儿童发生复杂性阑尾炎的风险较低,但单纯性阑尾炎总体风险与无过敏儿童相同。
  • 季节性抗原暴露降低复杂性阑尾炎风险,而持续抗组胺药治疗增加复杂性阑尾炎风险。

研究设计与样本

  • 先进行横断面分析比较过敏与非过敏儿童阑尾炎病例的绝对风险和比值比,再进行纵向分析比较过敏儿童与匹配对照的发病率和风险比。

主要发现

  • 随访期间20.4%的儿童发生过敏,0.6%发生阑尾炎。
  • 阑尾炎患儿中,非过敏儿童复杂性阑尾炎比例为18.9%(948/5016),过敏儿童为12.8%(173/1351),P<0.001。
  • 过敏儿童复杂性阑尾炎调整OR为0.80(95%CI 0.67-0.96,P=0.021)。
  • 纵向分析中,过敏儿童复杂性阑尾炎发病率0.13/1000人年 vs 对照0.20/1000人年,HR 0.68(95%CI 0.58-0.81,P<0.001);单纯性阑尾炎发病率0.91 vs 0.91,HR 1.00(95%CI 0.94-1.07,P=0.932)。
  • 季节性抗原暴露调整OR为0.82(95%CI 0.71-0.94,P=0.004);持续抗组胺药治疗调整OR为2.28(95%CI 1.21-4.28,P=0.012)。

临床怎么用

  • 对于有过敏史的儿童,临床上可关注其阑尾炎进展为复杂性的风险可能较低。
  • 儿童阑尾炎评估时,需注意持续使用抗组胺药可能与复杂性阑尾炎风险升高相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In a nationwide cohort the potentially protective association between allergy and complicated appendicitis was analysed, and the influence of seasonal antigens, antihistamine treatment, and timing of allergy onset assessed. METHODS: Some 1 112 571 children born between 2000 and 2010 were followed from birth until the end of 2014. A cross-sectional analysis of appendicitis cases, with comparison of allergic versus non-allergic children for absolute risk and odds of complicated appendicitis was first undertaken. This was followed by a longitudinal analysis of children with allergy and matched controls who had never had an allergy, for incidence rate and hazard of subsequent complicated or simple appendicitis. RESULTS: Of all children, 20.4 per cent developed allergy and 0.6 per cent had appendicitis during follow-up. Among children with appendicitis, complicated appendicitis was more common among non-allergic children (18.9 per cent, 948 of 5016) than allergic children (12.8 per cent, 173 of 1351) (P < 0.001), and allergic children had a lower adjusted odds of complicated appendicitis (adjusted odds ratio (OR) 0.80, 95 per cent c.i. 0.67 to 0.96; P = 0.021 ). The risk of complicated appendicitis among children with manifest allergy was reduced by one-third in the longitudinal analysis (incidence rate 0.13 versus 0.20 per 1000 person-years; hazard ratio (HR) 0.68, 95 per cent c.i. 0.58 to 0.81; P < 0.001), whereas the risk of simple appendicitis remained unchanged (incidence rate 0.91 versus 0.91; HR 1.00, 0.94 to 1.07; P = 0.932 ). Seasonal antigen exposure was a protective factor (adjusted OR 0.82, 0.71 to 0.94; P = 0.004) and ongoing antihistamine medication a risk factor (adjusted OR 2.28, 1.21 to 4.28; P = 0.012). CONCLUSION: Children with allergy have a lower risk of complicated appendicitis, but the same overall risk of simple appendicitis. Seasonal antigen exposure reduced, and antihistamine treatment increased, the risk of complicated disease.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Omling E, Salö M, Stenström P, et al. Nationwide paediatric cohort study of a protective association between allergy and complicated appendicitis. Br J Surg. 2021. PMID: 34689186. doi:10.1093/bjs/znab326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。